Published ahead of print on May 13, 2005, doi:10.1164/rccm.200501-017PP
American Journal of Respiratory and Critical Care Medicine Vol 172. pp. 417-422, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200501-017PP
Oxidative Stress in Pulmonary Fibrosis
A Possible Role for Redox Modulatory Therapy
Vuokko L. Kinnula,
Cheryl L. Fattman,
Roderick J. Tan and
Tim D. Oury
Division of Pulmonary Medicine, Department of Medicine, University of Helsinki, Helsinki, Finland; and Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania
Correspondence and requests for reprints should be addressed to Vuokko Kinnula, M.D., Ph.D., Department of Medicine, Division of Pulmonary Medicine, University of Helsinki, P.O. Box 22 (Haartmaninkatu 4), FI-00014 Helsinki, Finland. E-mail: vuokko.kinnula{at}helsinki.fi
ABSTRACT
Idiopathic ulmonary fibrosis (histopathology of usual interstitial pneumonia) is a progressive lung disease of unknown etiology. No treatment has been shown to improve the prognosis of the patients with this disease. Recent evidence, including the observations that the patients with idiopathic pulmonary fibrosis have higher levels of oxidant stress than control patients, and a recent multicenter European study examining the effect of the antioxidant N-acetylcysteine on the progression of idiopathic pulmonary fibrosis suggest that the cellular redox state may play a significant role in the progression of this disease. These complex mechanisms include activation of growth factors as well as regulation of matrix metalloproteinases and protease inhibitors. Potential future approaches for the therapy of interstitial pulmonary fibrosis may involve synthetic agents able to modulate cellular redox state. Investigation into therapeutic approaches to inhibit oxidant-mediated reactions in the initiation and progression of pulmonary fibrosis may provide hope for the future treatment of this disease.
Key Words: antioxidant idiopathic pulmonary fibrosis oxidant radical
This article has been cited by other articles:

|
 |

|
 |
 
S. W. Aesif, V. Anathy, M. Havermans, A. S. Guala, K. Ckless, D. J. Taatjes, and Y. M.W. Janssen-Heininger
In Situ Analysis of Protein S-Glutathionylation in Lung Tissue Using Glutaredoxin-1-Catalyzed Cysteine Derivatization
Am. J. Pathol.,
July 1, 2009;
175(1):
36 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. W. Janssen-Heininger and A. van der Vliet
Oxidants Are Not All Created Equal: Could Hydrogen Peroxide Actually Be Good for Our Lungs?
Am. J. Respir. Crit. Care Med.,
April 15, 2009;
179(8):
627 - 628.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Borzone, L. F. Liberona, A. P. Bustamante, C. G. Saez, P. R. Olmos, A. Vecchiola, A. Villagran, C. Serrano, and T. P. Reyes
Differences in lung glutathione metabolism may account for rodent susceptibility in elastase-induced emphysema development
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2009;
296(4):
R1113 - R1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Kliment, J. M. Englert, B. R. Gochuico, G. Yu, N. Kaminski, I. Rosas, and T. D. Oury
Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis
J. Biol. Chem.,
February 6, 2009;
284(6):
3537 - 3545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Umstead, W. M. Freeman, V. M. Chinchilli, and D. S. Phelps
Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat
Am J Physiol Lung Cell Mol Physiol,
January 1, 2009;
296(1):
L14 - L29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Vuorinen, S. Ohlmeier, O. Lepparanta, K. Salmenkivi, M. Myllarniemi, and V. L. Kinnula
Peroxiredoxin II Expression and Its Association With Oxidative Stress and Cell Proliferation in Human Idiopathic Pulmonary Fibrosis
J. Histochem. Cytochem.,
October 1, 2008;
56(10):
951 - 959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Behr and J. H. Ryu
Pulmonary hypertension in interstitial lung disease
Eur. Respir. J.,
June 1, 2008;
31(6):
1357 - 1367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sato, T. Shimosato, W. G. Alvord, and D. M. Klinman
Suppressive Oligodeoxynucleotides Inhibit Silica-Induced Pulmonary Inflammation
J. Immunol.,
June 1, 2008;
180(11):
7648 - 7654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Ye, Y. Dalavanga, N. Poulakis, S. U. Sixt, J. Guzman, and U. Costabel
Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis
Eur. Respir. J.,
May 1, 2008;
31(5):
1030 - 1036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Gao, J. R. Koenitzer, J. M. Tobolewski, D. Jiang, J. Liang, P. W. Noble, and T. D. Oury
Extracellular Superoxide Dismutase Inhibits Inflammation by Preventing Oxidative Fragmentation of Hyaluronan
J. Biol. Chem.,
March 7, 2008;
283(10):
6058 - 6066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Clement and E. Eber
Interstitial lung diseases in infants and children
Eur. Respir. J.,
March 1, 2008;
31(3):
658 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells
Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status
Am. J. Respir. Crit. Care Med.,
January 15, 2008;
177(2):
190 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Maher, A. U. Wells, and G. J. Laurent
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Eur. Respir. J.,
November 1, 2007;
30(5):
835 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kabuyama, K. Oshima, T. Kitamura, M. Homma, J. Yamaki, M. Munakata, and Y. Homma
Involvement of selenoprotein P in the regulation of redox balance and myofibroblast viability in idiopathic pulmonary fibrosis.
Genes Cells,
November 1, 2007;
12(11):
1235 - 1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Noth and F. J. Martinez
Recent Advances in Idiopathic Pulmonary Fibrosis
Chest,
August 1, 2007;
132(2):
637 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathan, P. W. Noble, and R. M. Tuder
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots
Am. J. Respir. Crit. Care Med.,
May 1, 2007;
175(9):
875 - 880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Reynaert, E. F. M. Wouters, and Y. M. W. Janssen-Heininger
Modulation of Glutaredoxin-1 Expression in a Mouse Model of Allergic Airway Disease
Am. J. Respir. Cell Mol. Biol.,
February 1, 2007;
36(2):
147 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sato, M. Takeno, K. Honma, H. Yamauchi, Y. Saito, T. Sasaki, H. Morikubo, Y. Nagashima, S. Takagi, K. Yamanaka, et al.
Heme Oxygenase-1, a Potential Biomarker of Chronic Silicosis, Attenuates Silica-induced Lung Injury
Am. J. Respir. Crit. Care Med.,
October 15, 2006;
174(8):
906 - 914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Tan, C. L. Fattman, L. M. Niehouse, J. M. Tobolewski, L. E. Hanford, Q. Li, F. A. Monzon, W. C. Parks, and T. D. Oury
Matrix Metalloproteinases Promote Inflammation and Fibrosis in Asbestos-Induced Lung Injury in Mice
Am. J. Respir. Cell Mol. Biol.,
September 1, 2006;
35(3):
289 - 297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Carnevali, F. Luppi, D. D'Arca, A. Caporali, M. P. Ruggieri, M. V. Vettori, A. Caglieri, S. Astancolle, F. Panico, P. Davalli, et al.
Clusterin Decreases Oxidative Stress in Lung Fibroblasts Exposed to Cigarette Smoke
Am. J. Respir. Crit. Care Med.,
August 15, 2006;
174(4):
393 - 399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and M. P. Keane
Update in diffuse parenchymal lung diseases 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1066 - 1071.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Tan, J. S. Lee, M. L. Manni, C. L. Fattman, J. M. Tobolewski, M. Zheng, J. K. Kolls, T. R. Martin, and T. D. Oury
Inflammatory Cells as a Source of Airspace Extracellular Superoxide Dismutase after Pulmonary Injury
Am. J. Respir. Cell Mol. Biol.,
February 1, 2006;
34(2):
226 - 232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Walter, H. R. Collard, and T. E. King Jr.
Current perspectives on the treatment of idiopathic pulmonary fibrosis.
Proceedings of the ATS,
January 1, 2006;
3(4):
330 - 338.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|